Barely Significant
← all excerpts

Randomized Clinical Trial: Crofelemer Treatment in Women With Diarrhea-Predominant Irritable Bowel Syndrome.

Clin Transl Gastroenterol · 2019 · PMC6970555 · PMID 31800542

Europe PMCDOI
1
hedged sentence
0.0700
closest p · 1.4× alpha
0.0700
boldest claim

The sentences

approached significanceP = 0.07so close (0.05 < p ≤ 0.1)
When comparing women in the crofelemer and placebo groups, the difference of 17.5% was statistically significant in month 2 ( P = 0.006) and the difference of 11.6% approached significance in month 3 ( P = 0.07).

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.